Transarterial therapies in HCC: Does embolization increase survival?

被引：6

作者：

Forner, Alejandro ^{[1
]}

Trinchet, Jean-Claude ^{[2
]}

机构：

[1] Univ Barcelona, CIBEREHD, IDIBAPS, Hosp Clin Barcelona,BCLC Grp,Liver Unit, Barcelona, Spain

[2] Univ Paris 13, Hop Jean Verdier, AP HP, Serv Hepatogastroenterol,UFR SMBH, Bondy, France

来源：

JOURNAL OF HEPATOLOGY | 2009年 / 51卷 / 06期

关键词：

UNRESECTABLE HEPATOCELLULAR-CARCINOMA; DRUG ELUTING BEADS; CHEMOEMBOLIZATION; TRIALS;

D O I：

10.1016/j.jhep.2009.09.009

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：981 / 983

页数：3

共 12 条

[1] Interventional radiology as a fine art [J].

Beaugrand, Michel ;

Trinchet, Jean-Claude .

JOURNAL OF HEPATOLOGY, 2007, 46 (03) :362-364

[2] Management of hepatoceullular carcinoma [J].

Bruix, J ;

Sherman, M .

HEPATOLOGY, 2005, 42 (05) :1208-1236

[3] Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: A pilot clinical study [J].

Lencioni, Riccardo ;

Crocetti, Laura ;

Petruzzi, Pasquale ;

Vignali, Claudio ;

Bozzi, Elena ;

Della Pina, Clotilde ;

Bargellini, Irene ;

Cion, Dania ;

Oliveri, Filippo ;

De Simone, Paolo ;

Bartolozzi, Carlo ;

Brunetto, Maurizia ;

Filipponi, Franco .

JOURNAL OF HEPATOLOGY, 2008, 49 (02) :217-222

[4] Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival [J].

Llovet, JM ;

Bruix, J .

HEPATOLOGY, 2003, 37 (02) :429-442

[5] Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial [J].

Llovet, JM ;

Real, MI ;

Montaña, X ;

Planas, R ;

Coll, S ;

Aponte, J ;

Ayuso, C ;

Sala, M ;

Muchart, J ;

Solà, R ;

Rodés, J ;

Bruix, J .

LANCET, 2002, 359 (9319) :1734-1739

[6] Design and endpoints of clinical trials in hepatocellular carcinoma [J].

Llovet, Josep M. ;

Di Bisceglie, Adrian M. ;

Bruix, Jordi ;

Kramer, Barnett S. ;

Lencioni, Riccardo ;

Zhu, Andrew X. ;

Sherman, Morris ;

Schwartz, Myron ;

Lotze, Michael ;

Talwalkar, Jayant ;

Gores, Gregory J. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (10) :698-711

[7] Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma [J].

Lo, CM ;

Ngan, H ;

Tso, WK ;

Liu, CL ;

Lam, CM ;

Poon, RTP ;

Fan, ST ;

Wong, J .

HEPATOLOGY, 2002, 35 (05) :1164-1171

[8] Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: Results of an open-label study of 62 patients [J].

Malagari, Katerina ;

Chatzimichael, Katerina ;

Alexopoulou, Efthymia ;

Kelekis, Alexios ;

Hall, Brenda ;

Dourakis, Spyridon ;

Delis, Spyridon ;

Gouliamos, Athanasios ;

Kelekis, Dimitrios .

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2008, 31 (02) :269-280

[9] The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials [J].

Moher, D ;

Schulz, KF ;

Altman, DG .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :657-662

[10] Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial [J].

Okusaka, Takuji ;

Kasugai, Hiroshi ;

Shioyama, Yasukazu ;

Tanaka, Katsuaki ;

Kudo, Masatoshi ;

Saisho, Hiromitsu ;

Osaki, Yukio ;

Sata, Michio ;

Fujiyama, Shigetoshi ;

Kumada, Takashi ;

Sato, Keiko ;

Yamamoto, Seiichiro ;

Hinotsu, Shiro ;

Sato, Tosiya .

JOURNAL OF HEPATOLOGY, 2009, 51 (06) :1030-1036

← 1 2 →